Global Blocking Buffers Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Blocking Buffers Market, By Composition (Salt Solution, Detergent, Blocking Agent), End- Users (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies and Contract Research Organisations, Blood Banks, Research and Academic Laboratories, Others), Application (Quantitative Western Blot, Chemiluminescent Western Blots, In-Cell Western Assay, In-Gel Western, Protein Array, Glycoprotein Detection) – Industry Trends and Forecast to 2029.

Blocking Buffers Market

Global Blocking Buffers Market Analysis and Size

Blotting techniques are increasingly gaining importance globally that is used to separate and identify the proteins. Blocking buffers are one of the techniques that are used for this purpose. Blocking buffers are composed of slat solutions which include tris-buffered saline (TBS; 50 mM Tris and 150 mM NaCl, pH 7.6) and phosphate-buffered saline (PBS; 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4).                                               

  • Data Bridge Market Research analyses that the blocking buffers market is expected to undergo a CAGR of 5.00% during the forecast period of 2022 to 2029. “Salt Solution” dominates the end user segment of the blocking buffers market owing to the growing number of hospitals especially in the developing economies.   

Global Blocking Buffers Market Definition

Blocking buffers are non-specific protein solutions that passively adsorbs to all remaining binding surfaces. Blocking buffers is a solution of irrelevant protein, mixture of proteins, or other compound that connects non-specifically to plate surfaces. The blocking buffers are composed of salt solutions and blocking agent.                   

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Composition (Salt Solution, Detergent, Blocking Agent), End- Users (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies and Contract Research Organisations, Blood Banks, Research and Academic Laboratories, Others), Application (Quantitative Western Blot, Chemiluminescent Western Blots, In-Cell Western Assay, In-Gel Western, Protein Array, Glycoprotein Detection)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Thermo Fisher Scientific Inc. (US), LI-COR, Inc. (US), Calbiotech, Inc. (US), CANDOR Bioscience GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Rockland Immunochemicals, Inc. (US), Advansta Inc. (US), CryoLife, Inc. (US), LifeNet Health (US), LeMaitre Vascular, Inc. (US), Boston Scientific Corporation (US), Hancock Jaffe Laboratories, Inc. (US), KARL STORZ SE & Co. KG (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Systems Corporation (Japan), Novartis AG (Switzerland), Pfizer Inc. (US), Merck & Co., Inc. (Germany), Novo Nordisk A/S (Denmark), Amgen Inc. (US), AstraZeneca (UK), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Abbott (US), Bausch & Lomb Incorporated (US), BD (US) and AbbVie Inc. (US)    

Market Opportunities

  • Growth in the awareness about the benefits of maintaining personal health
  • Increasing incidence rate of HIV/AIDS  
  • Rising research and development opportunities

Blocking Buffers Market Dynamics

Drivers

  • Rising Prevalence of Conditions

Growing incidence rate of several conditions globally is one of the major factors fostering the growth of the market. Increasing incidence rate of human immunodeficiency virus (HIV) is directly propelling the market growth rate. More than 1 million cases per year are witnessed in India and this condition may prevail for lifetime if not treated properly.    

  • Research and Development Proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the advancements in medical technologies and devices is also bolstering the market growth rate.

  • Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, increasing applications of western blotting technique and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, unhealthy lifestyle of individuals, rising internet penetration rate, growing use of western blotting results in generation of large amount of data, which needs to be stored, organized, and interpreted, product development and commercialization and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges Global Blocking Buffers Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services, dearth of skilled medical professionals, approximation in the results and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, emergence of alternative technologies, limited insurance coverage and regulatory compliance, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This blocking buffers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the blocking buffers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Blocking Buffers Market

The COVID-19 pandemic essentially affected the market. This is because of the fact that majority of the healthcare resources were directed towards meeting the demand arising out of COVID-19 patients. Postponement of non-elective surgeries and non-essential healthcare procedures has further derailed the market growth rate in this pandemic period. Shutdown of research facilities and a halt put on the projects of pharmaceutical and biotechnological industries too derailed the market growth rate. Further, restrictions imposed on travel owing to the lockdown regulations further challenged the market growth rate in this period. However, the post pandemic period will help to generate profits and revenues. 

Recent Development

  • In February 2021, in June 2019, Bio-Techne Corporation reached agreement to acquire B-MoGen Biotechnologies Inc. this acquisition would prove to be fruitful for the company to operate in the market in the long run.
  • In November 2019, Bio-Rad Laboratories, Inc. launched EveryBlot Blocking Buffer, a western blot blocking reagent that offers 5-minute blocking time and produces higher signal and lower background levels.

Global Blocking Buffers Market Scope

The blocking buffers market is segmented on the basis of composition, end-users and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Composition

  • Salt Solution
  • Detergent
  • Blocking Agent

On the basis of composition, blocking buffers market is segmented into salt solution, detergent, and blocking agent. 

End-users

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies and Contract Research Organisations
  • Blood Banks
  • Research and Academic Laboratories
  • Others

The end- users segment of blocking buffers market is divided into hospitals, clinical laboratories, pharmaceutical and biotechnology companies and contact research organizations, blood banks, research and academic laboratories, and others.

Application

  • Quantitative Western Blot
  • Chemiluminescent Western Blots
  • In-Cell Western Assay
  • In-Gel Western
  • Protein Array
  • Glycoprotein Detection

Application segment of blocking buffers market is divided into quantitative western blot, chemiluminescent western blots, in-cell western assay, in-gel western, protein array, and glycoprotein detection.

Blocking Buffers Market Regional Analysis/Insights

The blocking buffers market is analysed and market size insights and trends are provided by country, composition, end-users and application as referenced above.

The countries covered in the blocking buffers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the blocking buffers market because of the strong base of healthcare facilities, widespread utilization of medications, increasing occurrence of lifestyle diseases, increasing consciousness regarding the essence of maintaining good health and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, increasing occurrence of lifestyle diseases, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The blocking buffers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for blocking buffers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the blocking buffers market. The data is available for historic period 2010-2020.

Competitive Landscape and Blocking Buffers Market Share Analysis

The blocking buffers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to blocking buffers market.

Some of the major players operating in the blocking buffers market are:

  • Thermo Fisher Scientific Inc. (US)
  • LI-COR, Inc. (US)
  • Calbiotech, Inc. (US)
  • CANDOR Bioscience GmbH (Germany)
  • Bio-Rad Laboratories, Inc. (US)
  • Rockland Immunochemicals, Inc. (US)
  • Advansta Inc. (US)
  • CryoLife, Inc. (US)
  • LifeNet Health (US)
  • LeMaitre Vascular, Inc. (US)
  • Boston Scientific Corporation (US)
  • Hancock Jaffe Laboratories, Inc. (US)
  • KARL STORZ SE & Co. KG (Germany)
  • Getinge AB (Sweden)
  • Medtronic (Ireland)
  • Terumo Systems Corporation (Japan)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (US)
  • Merck & Co., Inc. (Germany)
  • Novo Nordisk A/S (Denmark)
  • Amgen Inc. (US)
  • AstraZeneca (UK)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Sanofi (France)
  • Johnson & Johnson Services, Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • Abbott (US)
  • Bausch & Lomb Incorporated (US)
  • BD (US)
  • AbbVie Inc. (US)   

Research Methodology : Global Blocking Buffers Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available : Global Blocking Buffers Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Blocking Buffers Market is Projected to Grow at a CAGR of 5.00% During the Forecast Period of 2022 to 2029.
Thermo Fisher Scientific Inc. (US), LI-COR, Inc. (US), Calbiotech, Inc. (US), CANDOR Bioscience GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Rockland Immunochemicals, Inc. (US), Advansta Inc. (US), CryoLife, Inc. (US), Boston Scientific Corporation (US), KARL STORZ SE & Co. KG (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Systems Corporation (Japan), Novartis AG (Switzerland), Pfizer Inc. (US), Merck & Co., Inc. (Germany), Novo Nordisk A/S (Denmark), Amgen Inc. (US), AstraZeneca (UK), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Abbott (US), Bausch & Lomb Incorporated (US), BD (US) and AbbVie Inc. (US) are the Major Companies Operating in Blocking Buffers Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Blocking Buffers Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.